Pashtoon Murtaza Kasi, Ari David Baron, Arvind Chaudhry, Laura LaNiel Tenner, Namrata Vijayvergia, Michael Francis Driscoll, Daniel L. Adams, Alexis B. Duffy, Hallgeir Rui, Richard G. Pestell, Patrick J. Vittner, Joseph Meidling, Jacob P. Lalezari. "Leronlimab in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab for patients with refractory metastatic colorectal cancer (mCRC): The phase 2 CLOVER study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15525